Attitudes of families affected by adrenoleukodystrophy toward prenatal diagnosis, presymptomatic and carrier testing, and newborn screening

Genetic Testing

Volumn 11, Issue 3, 2007, Pages 296-302

  Schaller, Jean ^a,d   Moser, Hugo ^b   Begleiter, Michael L ^c   Edwards, Janice ^a  

^a Myriad Genetic Laboratories   (United States)

^b KENNEDY KRIEGER INSTITUTE   (United States)

^c UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENOLEUKODYSTROPHY; ADULT; ARTICLE; BIRTH; COMPUTER PROGRAM; DATA BASE; DAUGHTER; FAMILY ATTITUDE; FEMALE; HETEROZYGOTE DETECTION; HUMAN; INHERITANCE; MALE; NEWBORN PERIOD; NEWBORN SCREENING; PRENATAL DIAGNOSIS; PROSPECTIVE STUDY; QUESTIONNAIRE; RISK ASSESSMENT;

ADOLESCENT; ADRENOLEUKODYSTROPHY; ADULT; AGED; AGED, 80 AND OVER; ATTITUDE TO HEALTH; FAMILY HEALTH; FEMALE; GENETIC SCREENING; HETEROZYGOTE DETECTION; HUMANS; INFANT, NEWBORN; MALE; MIDDLE AGED; NEONATAL SCREENING; PREGNANCY; PRENATAL DIAGNOSIS; QUESTIONNAIRES;

EID: 35348949543     PISSN: 10906576     EISSN: None     Source Type: Journal    
DOI: 10.1089/gte.2007.0001     Document Type: Article

References (40)

1. Aubourg P, Blanche S, Jambaque I, Rocchiccioli F, Kalifa G, Naud-Saudreau C, Rolland MO, Debre M, Chaussain JL, Griscelli C, Fischer MD (1990) Reversal of early neurologic and neuroradiologic manifestations of X-linked adrenoleukodystrophy by bone marrow transplantation. N Engl J Med 322:1860-1866.
2. Bailey DB (2004) Newborn screening for Fragile X syndrome. Ment Retard Dev Disabil Res Rev 10:3-10.
3. Bezman L, Moser HW (1998) Incidence of X-linked adrenoleukodystrophy and the relative frequency of its phenotypes. Am J Med Genet A 76:415-419.
4. Bezman L, Moser AB, Raymond GV, Rinaldo PR, Watkins PA, Smith KD, Kass NE, Moser HW (2001) Adrenoleukodystrophy: incidence, new mutation rate, and results of extended family screening. Ann Neurol 49:512-517.
5. Campbell E, Ross L (2003) Parental attitudes regarding newborn screening of PKU and DMD. Am J Med Genet A 120:209-214.
6. Coll MJ, Palau N, Camps C, Ruiz M, Pampols T, Giros M (2005) Xlinked adrenoleukodystrophy in Spain. Identification of 26 novel mutations in the ABCD1 gene in 80 patients. Improvement of genetic counseling in 162 relative females. Clin Genet 67:418-424.
7. Costakos D, Abramson RK, Edwards JG, Rizzo WB, Best RG (1991) Attitudes toward presymptomatic testing and prenatal diagnosis for adrenoleukodystrophy among affected families. Am J Med Genet A 41:295-300.
8. Cox C, Dubey P, Raymond GV, Mahmood A, Moser A, Moser HW (2005) Cognitive evaluation of neurologically asymptomatic boys with x-linked adrenoleukodystrophy. Arch Neurol 63:69-73.
9. Dubey P, Raymond GV, Moser AB, Kharkar S, Bezman L, Moser HW (2004) Adrenal insufficiency in asymptomatic adrenoleukodystrophy patients identified by very long-chain fatty acid screening. J Pediatr 146:528-532.
10. El-Deiry SS, Naidu S, Blevins LS, Ladenson PW (1996) Assessment of adrenal function in women heterozygous for adrenoleukodystrophy. J Clin Endocrinol Metab 82:856-860.
11. Gartner J, Braun A, Holzinger A, Roerig P, Lenard HG, Roscher AA (1997) Clinical and genetic aspects of X-linked adrenoleukodystrophy. Neuropediatrics 29:3-13.
12. Gondcaille C, Depreter M, Fourcade S, Lecca MR, Leclercq S, Martin PGP, Pineau T, Cadepond F, ElEtr M, Betrand N, Beley A, Duclos S, De Craemer D, Roels F, Savary S, Bugaut M (2005) Phenylbutyrate up-regulates the adrenoleukodystrophy-related gene as a nonclassical peroxisome proliferator. J Cell Biol 169:93-104.
13. Grace J, El Toukhy T, Braude P (2004) Pre-implantation genetic testing. Br J Obstet Gynaecol 111:1165-1173.
14. Hitomi T, Mezaki T, Tsujii T, Kinoshita M, Tomimoto H, Ikeda A (2003) Improvement of central motor conduction after bone marrow transplantation in adrenoleukodystrophy. J Neurol Neurosurg Psychiatry 74:373-375.
15. Igarashi M, Schaumburg H, Powers J, Kishimoto Y, Kolodny E, Suzuki K (1976) Fatty acid abnormality in adrenoleukodystrophy. J Neurochem 26:851-860.
16. Krivit W (2004) Allogeneic stem cell transplantation for the treatment of lysosomal and peroxisomal metabolic diseases. Springer Semin Immunol 26:119-132.
17. Kuliev A, Rechitsky S, Tur-Kaspa I, Verlinsky Y (2005) Preimplantation genetics improving access to stem cell therapy. Ann N Y Acad Sci 1054:223-227.
18. Maier EM, Kammerer S, Muntau AC, Wichers M, Braun A, Roscher AA (2002) Symptoms in carriers of adrenoleukodystrophy relate to skewed X inaction. Ann Neurol 52:683-688.
19. Maria BL, McCann K, Moser H, Naidu S (2003) Leukodystrophies: pathogenesis, diagnosis, strategies, therapies, and future research directions. J Child Neurol 18:578-590.
20. Menkes JH, Curbo LM (1977) Adrenoleukodystrophy. Neurology 27:928-932.
21. Moser AB, Moser HW (1999) The prenatal diagnosis of X-linked adrenoleukodystrophy. Prenat Diagn, 19:46-48.
22. Moser H, Smith KD, Watkins PA, Powers J, Moser AB (2001) X-linked adrenoleukodystrophy. In Scriver, CR Beaudet, AL Sly, WS Valle D (eds) The metabolic & molecular bases of inherited disease. McGraw-Hill, New York, pp 3257-3301.
23. Moser H, Dubey P, Fatemi A (2004) Progress in X-linked adrenoleukodystrophy. Curr Opin Neurol 17:263-269.
24. Moser HW, Moser AB, Trojak JE, Supplee SW (1983) Identification of female carriers of adrenoleukodystrophy. J Pediatr 103:54-59.
25. Moser HW, Borel, J (1995) Dietary management of X-linked adrenoleukodystrophy. Annu Rev Nutr 15:379-397.
26. Moser HW (1997) Adrenoleukodystrophy: phenotype, genetics, pathogenesis, and therapy. Brain 120:1485-1508.
27. Moser HW, Loes DJ, Melhem ER, Raymond GV, Bezman L, Cox C, Lu S (2000) X-linked adrenoleukodystrophy: overview and prognosis as a function of age and brain magnetic resonance imaging abnormality. A study involving 372 patients. Neuropediatrics 31:227-239.
28. Moser HW, Barker PB (2005) Magnetic resonance spectroscopy: a new guide for the therapy of adrenoleukodystrophy. Neurology 64:406-407.
29. Moser HW, Raymond GV, Dubey P (2005a) Adrenoleukodystrophy: new approaches to a neurodegenerative disease. JAMA 294:3131-3134.
30. Moser HW, Raymond GV, Lu SE, Muenz LR, Moser AB, Xu J, Jones R, Loes DJ, Melhelm ER, Dubey P, Bezman L, Brereton NH, Odone A (2005b) Follow-up of 89 Lorenzo's oil-treated asymptomatic adrenoleukodystrophy patients. Arch Neurol 62:1073-1080.
31. Ogilvie CM, Braude PR, Scriven PN (2005) Preimplantation genetic diagnosis - an overview. J Histochem Cytochem 53:255-260.
32. Pai GS, Khan M, Barbosa E, Key LL, Craver JR, Cure JK, Betros R, Singh I (2000) Lovastatin therapy for X-linked adrenoleukodystrophy: clinical and biochemical observations on 12 patients. Mol Genet Metab 69:312-322.
33. Paintlia AS, Gilg AG, Khan M, Singh AK, Barbosa E, Singh I (2003) Correlation of very long chain fatty acid accumulation and inflammatory disease progression in childhood X-ALD: implication for potential therapies. Neurobiol Dis 14:425-439.
34. Peters C, Charnas LR, Tan Y, Ziegler RS, Shapiro EG, DeFor T, Grewal SS, Orchard PJ, Abel SL, Goldman AI, Ramsay NKC, Dusenbery KE, Loes DJ, Lockman LA, Kato S, Aubourg PR, Moser HW, Krivit W (2004) Cerebral X-linked adrenoleukodystrophy: The international hematopoietic cell transplantation experience from 1982 to 1999. Blood 104:881-888.
35. Rechitsky S, Kuliev A, Tur-Kaspa I, Morris R, Verlinsky Y (2004) Preimplantation genetic diagnosis with HLA matching. Reprod Bio-Med Online 9:210-221.
36. Schaumburg HH, Powers JM, Raine CS, Suzuki K, Richardson EP (1975) Adrenoleukodystrophy: a clinical and pathological study of 17 cases. Arch Neurol 32:577-591.
37. Sermon K, Van Steirteghem A, Liebaers I (2004) Preimplantation genetic diagnosis. Lancet 363:1633-1641.
38. Shapiro E, Krivit W, Lockman L, Jambaque I, Peters C, Cowan M, Harris R, Blanche S, Bordigoni P, Loes D, Ziegler R, Crittenden M, Ris D, Berg B, Cox C, Moser H, Fischer A, Aubourg P (2000) Long-term effect of bone-marrow transplantation for childhood-onset cerebral X-linked adrenoleukodystrophy. Lancet 356:713-718.
39. Suzuki Y, Isogai K, Teramoto T, Tashita H, Shimozawa N, Nishimura M, Asano T, Oda M, Kamei A, Ishiguro H, Kato S, Ohashi T, Kobayashi H, Eto Y, Kondo N (2000) Bone marrow transplantation for the treatment of X-linked adrenoleukodystrophy. J Inherit Metab Dis 23:453-458.
40. Yamada T, Shinnoh N, Taniwaki T, Ohyagi T, Asahara H, Horiuchi I, Kira J (2000) Lovastatin does not correct the accumulation of very long-chain fatty acids in tissues of adrenoleukodystrophy protein-deficient mice. J Inherit Metab Dis 23:607-614.